Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00141687
Other study ID # C04-0348
Secondary ID ISRCTN56498577
Status Completed
Phase N/A
First received August 30, 2005
Last updated September 14, 2016
Start date December 2004
Est. completion date June 2008

Study information

Verified date September 2016
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

For women with a fetus in breech presentation, does early ECV (at 34 0/7 up to 35 weeks and 6/7 days) versus delayed ECV (not before 37 weeks and 0/7 days) increase or decrease the likelihood of cesarean section (CS)?


Description:

Primary Outcomes: Rate of Caesarean section

Secondary Outcomes: Rate of preterm birth

Other Outcomes: admission to neonatal intensive care unit ≥ 24 hours, perinatal or neonatal mortality or serious neonatal morbidity, serious fetal complications, maternal death or serious maternal morbidity, non-cephalic presentation at birth, women's views, and health care costs.

The Data Coordination for this study is being carried out at the Maternal, Infant Reproductive Health Research Unit at Sunnybrook and Women's College Health Sciences Centre.


Recruitment information / eligibility

Status Completed
Enrollment 1543
Est. completion date June 2008
Est. primary completion date June 2008
Accepts healthy volunteers No
Gender Female
Age group 14 Years to 45 Years
Eligibility Inclusion Criteria:

1. Women with any breech presentation

2. A live singleton fetus

3. Gestational age of 33 weeks 0 days to 35 weeks 6 days

Exclusion Criteria:

1. Contraindications to ECV (e.g. fetal heart rate abnormalities, abruptio placenta, major life-threatening fetal anomalies, uterine anomalies, hyper-extended fetal head, rupture of membranes, severe oligohydramnios, severe polyhydramnios)

2. Contraindications to early ECV (e.g. increased risk of preterm labour [such as past history of preterm labour in this or previous pregnancies], increased risk of abruptio placenta [such as maternal hypertension])

3. Contraindications to labour or vaginal delivery (e.g. placenta previa, previous classical CS)

4. Women planning delivery by CS if the fetus turns to cephalic

5. Women planning a vaginal delivery if the fetus remains breech

6. Women at increased risk of unstable lie (eg. grand multiparity)

7. Previous participation in EECV2 Trial

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Early ECV between 34 0/7 and 35 6/7 weeks
Early external cephalic version between 34 0/7 and 35 6/7 weeks of gestation
Delayed ECV at or after 37 0/7 weeks
Delayed external cephalic version at or after 37 0/7 weeks of gestation

Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (3)

Lead Sponsor Collaborator
McMaster University Canadian Institutes of Health Research (CIHR), University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of cesarean section Information not available Yes
Secondary Rate of pre-term births. Other outcomes: admission to neonatal intensive care unit = 24 hours, perinatal or neonatal mortality or serious neonatal morbidity, or others. Information not available Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04579835 - Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
Not yet recruiting NCT01922453 - Music and Sounds for ECV N/A
Completed NCT00516555 - EBIS: The Eindhoven Breech Intervention Study N/A
Completed NCT01487590 - Cephalic Version by Acupuncture-Moxibustion for Breech Presentation N/A
Completed NCT00890474 - Moxibustion for Fetus in Breech Presentation Phase 3
Terminated NCT00119184 - Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version Phase 1
Completed NCT05827627 - Simulation Techniques Used in Breech Birth Management Training N/A
Terminated NCT04538261 - Elevation of the Fetal Buttocks Prior to External Cephalic Version N/A
Recruiting NCT02801201 - Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation Phase 3
Completed NCT02331160 - Rebozo and External Cephalic Version in Breech Presentation. N/A
Completed NCT00896311 - Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women N/A
Completed NCT00901758 - Intravenous (IV) Nitroglycerin for Versions in Multiparous Women N/A
Not yet recruiting NCT02167841 - Comparison of Efficiency Between Practicing of Knee Chest Position and External Cephalic Version in Cases of Breech Presentation. N/A
Completed NCT01048398 - Remifentanil Versus Paracetamol for Pain Treatment External Cephalic Versions. Phase 3
Recruiting NCT04613778 - Correction of Breech Presentation With Laser Acupuncture N/A
Completed NCT01708018 - Effects of Relaxing Hydrotherapy in Third Trimester of Pregnancy N/A
Terminated NCT00465712 - Effect of Amnioinfusion on External Cephalic Version Successful Rate N/A
Recruiting NCT03827226 - Breech External Cephalic Version Intervention Trial
Completed NCT00813683 - Cephalic Version by Acupuncture for Breech Presentation N/A
Recruiting NCT06187948 - An Informative Video Before Planned External Cephalic Version N/A